BPEA Private Equity
Overview
BPEA is a Boston-based private equity firm focused on small and lower middle market buyout and growth investing, and customized investment solutions to meet investors' private equity goals. We offer dedicated small market buyout and growth investment programs as well as focused healthcare-only programs. We build diversified and balanced private equity programs that invest in fund managers and directly in companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sword Health | Jun 2021 | Series C | - |
| Ria Health | Mar 2025 | Series B | Co-investor |
| QE Solar | May 2021 | Buyout/LBO | Co-investor |
| Environ Energy | Jun 2026 | Growth Equity | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BPEA Private Equity based?
BPEA Private Equity is headquartered in Boston, Massachusetts, United States.
When was BPEA Private Equity founded?
BPEA Private Equity was founded in 2002.
How many portfolio companies does BPEA Private Equity have?
BPEA Private Equity has 7 portfolio companies in Caplight's dataset.
What are some companies in BPEA Private Equity's portfolio?
Portfolio companies visible on Caplight include Sword Health, Ria Health, QE Solar, Environ Energy.
What was BPEA Private Equity's most recent investment shown here?
BPEA Private Equity's most recent investment in this portfolio sample was in Environ Energy in 2026.
What sectors does BPEA Private Equity focus on?
BPEA Private Equity focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Energy & Sustainability, Healthcare & Life Sciences, Enterprise Software, FinTech, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech.
What company stages does BPEA Private Equity focus on?
Stage focus information for BPEA Private Equity is not publicly available.
What is BPEA Private Equity's AUM?
BPEA Private Equity's assets under management are estimated between $10.0B and $100.0B.